- Previous Close
226.80 - Open
226.60 - Bid --
- Ask --
- Day's Range
223.00 - 227.20 - 52 Week Range
192.70 - 392.00 - Volume
37,633 - Avg. Volume
48,007 - Market Cap (intraday)
2.865B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
28.31 - EPS (TTM)
7.89 - Earnings Date Mar 12, 2025
- Forward Dividend & Yield 3.00 (1.32%)
- Ex-Dividend Date Apr 22, 2024
- 1y Target Est
283.83
Tecan Group AG provides laboratory instruments and solutions for pharmaceutical, biotechnology and in-vitro diagnostic companies, university research departments, and diagnostic and other laboratories. It operates through Life Sciences Business and Partnering Business segments. The company offers liquid handling and automation, microplate readers and washers, consumables, NGS reagents, immunoassays and antibodies, and software; and Tecan Labwerx, an automation solution. It provides PARAMIT, a contract design and manufacturing service. The company operates in Switzerland, Europe, Other European countries, North America, Asia, and internationally. Tecan Group AG was founded in 1980 and is headquartered in Männedorf, Switzerland.
www.tecan.com3,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: TECN.SW
View MorePerformance Overview: TECN.SW
Trailing total returns as of 2/5/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TECN.SW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TECN.SW
View MoreValuation Measures
Market Cap
2.87B
Enterprise Value
2.84B
Trailing P/E
28.31
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.87
Price/Book (mrq)
2.04
Enterprise Value/Revenue
2.84
Enterprise Value/EBITDA
16.34
Financial Highlights
Profitability and Income Statement
Profit Margin
10.13%
Return on Assets (ttm)
2.94%
Return on Equity (ttm)
7.37%
Revenue (ttm)
1B
Net Income Avi to Common (ttm)
101.34M
Diluted EPS (ttm)
7.89
Balance Sheet and Cash Flow
Total Cash (mrq)
343.78M
Total Debt/Equity (mrq)
22.44%
Levered Free Cash Flow (ttm)
91.04M